OVERVIEW

Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease is organized by American Academy of Neurology (AAN).

Dates:
Released: 1/17/2020
Expires: 1/07/2023

Learning Objectives:
Upon completion of this podcast, participants will be able to understand that first ruling out PMP22 duplication/deletion, then considering a targeted genetic testing approach as outlined, in selected patients will increase diagnostic yield in Charcot-Marie-Tooth disease.

Credits
  • 0.5 CME
  • SPECIALITIES

    NeurologyOrthopedicsPodiatryPhysical Therapy

    RELATED ONLINE COURSES